PCLO.V - PharmaCielo Ltd.
TSXV - TSXV Delayed Price. Currency in CAD
Show:
Annual
Income Statement
Currency in USD. All numbers in thousandsBreakdown
ttm
8/30/2018
Total Revenue
0
0
Cost of Revenue
-
-
Gross Profit
-
-
Operating Expenses
Research Development
-
-
Selling General and Administrative
120
119
Total Operating Expenses
120
119
Operating Income or Loss
-120
-119
Interest Expense
-
-
Total Other Income/Expenses Net
-
-26
Income Before Tax
-146
-144
Income Tax Expense
-
-
Income from Continuing Operations
-146
-144
Net Income
-146
-144
Net Income available to common shareholders
-146
-144
Reported EPS
Basic
-
-1.19
Diluted
-
-1.19
Weighted average shares outstanding
Basic
-
122
Diluted
-
122
EBITDA
-
-119